• Axsome Therapeutics average return on tangible equity for 2023 was -278.06, a 83.61% increase from 2022.
• Axsome Therapeutics average return on tangible equity for 2022 was -1696.29, a 1085.31% decline from 2021.
• Axsome Therapeutics average return on tangible equity for 2021 was -143.11, a 84.66% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.